Every year, more people in the U.S. are diagnosed with skin cancer than all other cancers combined. Histology testing can be used to quickly distinguish between cancer and benign neoplasms of the skin and to determine cell of origin, allowing physicians to formulate timely treatment plans for their patients. Our robust menu of tools aid in dermatopathology diagnostics and treatment. Our portfolio of immunohistochemistry detection products delivers the high sensitivity and specificity you need from your assays. Our antibodies are ready to use on the fully-automated VENTANA BenchMark IHC/ISH staining platforms, reducing the time-to-result and resources required with manual or semi-automated solutions.
We offer 45 cornerstone and novel dermatopathology ready-to-use reagents, including key IHC and FITC antibodies which aid in the diagnosis of melanoma, basal cell carcinoma, squamous cell carcinoma and other less common dermatological malignancies.